X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3152) 3152
Book Review (1031) 1031
Publication (403) 403
Book Chapter (21) 21
Book / eBook (16) 16
Conference Proceeding (6) 6
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2497) 2497
humans (2262) 2262
oncology (1676) 1676
female (1025) 1025
male (963) 963
clinical neurology (962) 962
glioblastoma (936) 936
recurrent glioblastoma (933) 933
middle aged (814) 814
chemotherapy (789) 789
adult (779) 779
cancer (757) 757
brain neoplasms - drug therapy (743) 743
aged (664) 664
phase-ii trial (653) 653
temozolomide (599) 599
radiotherapy (567) 567
gliomas (561) 561
animals (559) 559
brain neoplasms - pathology (554) 554
glioblastoma multiforme (523) 523
medicine & public health (522) 522
bevacizumab (516) 516
glioma (507) 507
malignant glioma (485) 485
glioblastoma - drug therapy (475) 475
surgery (458) 458
brain neoplasms - therapy (448) 448
treatment outcome (439) 439
tumors (439) 439
recurrent (431) 431
survival (430) 430
brain tumors (419) 419
radiation-therapy (401) 401
recurrent malignant glioma (397) 397
care and treatment (395) 395
glioblastoma-multiforme (392) 392
high-grade gliomas (374) 374
phase-ii (366) 366
newly-diagnosed glioblastoma (365) 365
prognosis (353) 353
antineoplastic agents - therapeutic use (345) 345
glioblastoma - pathology (343) 343
brain-tumors (337) 337
neurology (332) 332
glioma - drug therapy (329) 329
dacarbazine - analogs & derivatives (300) 300
radiology, nuclear medicine & medical imaging (293) 293
malignant gliomas (291) 291
combined modality therapy (289) 289
brain neoplasms - mortality (286) 286
glioma - pathology (285) 285
research (283) 283
therapy (281) 281
magnetic resonance imaging (280) 280
recurrent glioblastoma-multiforme (279) 279
pharmacology & pharmacy (274) 274
adjuvant temozolomide (257) 257
glioblastoma - therapy (255) 255
retrospective studies (254) 254
recurrent malignant gliomas (251) 251
health aspects (249) 249
neurosciences (246) 246
high-grade glioma (245) 245
analysis (240) 240
brain neoplasms - radiotherapy (237) 237
clinical trials (237) 237
adolescent (236) 236
angiogenesis (236) 236
brain neoplasms - surgery (232) 232
immunotherapy (231) 231
survival analysis (230) 230
brain cancer (225) 225
cell line, tumor (223) 223
brain (219) 219
young adult (214) 214
central-nervous-system (213) 213
angiogenesis inhibitors - therapeutic use (211) 211
article (209) 209
antineoplastic combined chemotherapy protocols - therapeutic use (208) 208
glioma - therapy (208) 208
glioblastoma - mortality (203) 203
endothelial growth-factor (202) 202
multiforme (202) 202
neoplasm recurrence, local - drug therapy (199) 199
disease-free survival (195) 195
brain neoplasms - genetics (194) 194
mice (192) 192
radiation therapy (190) 190
survival rate (185) 185
clinical trials as topic (184) 184
trial (184) 184
development and progression (180) 180
aged, 80 and over (179) 179
brain neoplasms - metabolism (178) 178
child (178) 178
drug therapy (176) 176
disease progression (175) 175
dacarbazine - therapeutic use (169) 169
in-vivo (167) 167
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3100) 3100
French (39) 39
German (25) 25
Japanese (8) 8
Spanish (7) 7
Czech (2) 2
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 709 - 722
In patients with glioblastoma, the addition of bevacizumab to radiotherapy and temozolomide induction therapy and the use of bevacizumab maintenance therapy... 
CONCOMITANT RADIOCHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOBLASTOMA | CLINICAL-TRIALS | MALIGNANT GLIOMAS | QUALITY-OF-LIFE | RESPONSE ASSESSMENT CRITERIA | MULTIFORME | HIGH-GRADE GLIOMA | ENDOTHELIAL GROWTH-FACTOR | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Induction Chemotherapy | Male | Glioblastoma - radiotherapy | Bevacizumab | Young Adult | Dacarbazine - analogs & derivatives | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Quality of Life | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Dosage and administration | Research | Temozolomide | Drug therapy, Combination | Drug therapy | Glioblastoma multiforme | Nuclear magnetic resonance--NMR | Intravenous administration | Glucocorticoids | Brain cancer | Body weight | Glioblastoma | Radiation therapy | Survival | Patients | Quality of life | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 699 - 708
Journal Article
Nature, ISSN 0028-0836, 2010, Volume 468, Issue 7325, pp. 829 - 833
Journal Article
MEDICINE, ISSN 0025-7974, 07/2018, Volume 97, Issue 27, pp. e11254 - e11254
Journal Article
Cancer, ISSN 0008-543X, 03/2012, Volume 118, Issue 5, pp. 1302 - 1312
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article